REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
02/11/2025
Back to search
Official data from USPTO
GENECHRON
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
02/11/2025
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
08/30/2018
Registration date
02/11/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/11/2020
Last transaction
02/11/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
IT
Examiner
BUONGIORNO, CHRISTOPHER
Law office
L20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of a stylized helix with twelve squares inside colored blue, violet, orange, yellow and green; the stylized wording "GENECHRON" follows the helix design with the "GENE" in a capsule design that is shaded with the colors white and blue.
Holders and representatives
Holders
GENECHRON SRL
Representatives
Lawrence E. Abelman Abelman Frayne & Schwab
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagents for use in medical genetic testing; diagnostic biomarker reagents for medical purposes
Class 42
Scientific research in the field of genetics; scientific analysis in the field of genetics; scientific research advisory services in the field of gene therapy; information on the subject of scientific research in the fields of biochemistry and biotechnology; testing of biotechnology products; evaluation of chemical analyses; conducting clinical research and trials for others; analysis in the field of molecular biology; structural and functional analysis of genomes; scientific research for medical purposes in the area of cancerous diseases; research and development of products in the field of biotechnology
Class 44
Medical diagnostic services; genetic testing for medical purposes; laboratory analysis services in the fields of bacteriologychemistrybiochemistrybiotechnologycosmetics for the purpose of treating persons; medical analysis services for the diagnosis of cancer; medical testing of blood; RNA and DNA analysis for cancer diagnosis and prognosis; analysis of human serum for medical treatment; analysis of human tissues for medical treatment; genetic testing of animals for medical diagnostic or treatment purposes; medical services in the field of oncology; medical analysis services for cancer diagnosis and prognosis; genetic counseling; medical and health assessment services relating to DNAgenetics and genetic testing; medical screening
Publications
History of USPTO decisions and trademark events.
30 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/19/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/03/2020
FIMP
FINAL DISPOSITION PROCESSED
06/03/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/11/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
02/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/26/2019
PUBO
PUBLISHED FOR OPPOSITION
11/26/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/06/2019
ALIE
ASSIGNED TO LIE
10/21/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/15/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
10/15/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/15/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
10/15/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/15/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
06/18/2019
GNFR
FINAL REFUSAL E-MAILED
06/18/2019
CNFR
FINAL REFUSAL WRITTEN
06/18/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/13/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/17/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/17/2019
RFNT
REFUSAL PROCESSED BY IB
01/17/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
12/29/2018
RFRR
REFUSAL PROCESSED BY MPU
12/29/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/18/2018
CNRT
NON-FINAL ACTION WRITTEN
12/17/2018
DOCK
ASSIGNED TO EXAMINER
12/12/2018
MAFR
APPLICATION FILING RECEIPT MAILED
11/23/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/19/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
11/15/2018
Continuous trademark protection
Get notified about every new filing that threatens GENECHRON or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.